STANDARD BIOTOOLS INC. — Director's Dealing 2015

Sep 4, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2015-09-01

Reporting Person: Worthington Gajus Vincent (Director, PRESIDENT & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-01	Common Stock	M	715	$4.4461	Acquired	7530	Direct
2015-09-01	Common Stock	M	5285	$4.0828	Acquired	12815	Direct
2015-09-01	Common Stock	S	6000	$11.826	Disposed	6815	Direct
2015-09-02	Common Stock	M	6000	$4.0828	Acquired	12815	Direct
2015-09-02	Common Stock	S	6000	$11.2346	Disposed	6815	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-01	Employee Stock Option (Right to Buy)	$4.4461	M	715	Disposed	2017-05-07	Common Stock (715)	Direct
2015-09-01	Employee Stock Option (Right to Buy)	$4.0828	M	5285	Disposed	2019-11-17	Common Stock (5285)	Direct
2015-09-02	Employee Stock Option (Right to Buy)	$4.0828	M	6000	Disposed	2019-11-17	Common Stock (6000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	33029	Indirect

Footnotes

F1: Shares held directly by the Worthingon Family Trust dated March 6, 2007, a trust for the benefit of the Reporting Person and the Reporting Person's spouse, for which the Reporting Person and the Reporting Person's spouse serve as trustees.

F2: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2014.

F3: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $11.56 to $12.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F4: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $11.17 to $11.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F5: The shares subject to the Option fully vested on May 1, 2010.

F6: The shares subject to the Option fully vested on November 17, 2013.